Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · IEX Real-Time Price · USD
6.16
-0.25 (-3.90%)
At close: May 7, 2024, 4:00 PM
6.07
-0.09 (-1.46%)
After-hours: May 7, 2024, 7:24 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $483.86 million as of May 7, 2024. Its market cap has decreased by -50.88% in one year.
Market Cap
483.86M
Enterprise Value
-78.58M
1-Year Change
-50.88%
Ranking
Category
Stock Price
$6.16
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $483.86M, a decrease of -44.34%. That is a compound annual growth rate of -18.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2024 | 536.00M | - |
| May 3, 2024 | 536.00M | 4.22% |
| May 2, 2024 | 514.30M | 2.51% |
| May 1, 2024 | 501.70M | -0.18% |
| Apr 30, 2024 | 502.60M | -3.99% |
| Apr 29, 2024 | 523.50M | 1.63% |
| Apr 26, 2024 | 515.10M | -0.96% |
| Apr 25, 2024 | 520.10M | -5.47% |
| Apr 24, 2024 | 550.20M | -4.36% |
| Apr 23, 2024 | 575.30M | -0.43% |
| Apr 22, 2024 | 577.80M | 4.07% |
| Apr 19, 2024 | 555.20M | -0.31% |
| Apr 18, 2024 | 556.90M | -1.19% |
| Apr 17, 2024 | 563.60M | -5.59% |
| Apr 16, 2024 | 597.00M | -2.34% |
| Apr 15, 2024 | 611.30M | -3.81% |
| Apr 12, 2024 | 635.50M | -5.82% |
| Apr 11, 2024 | 674.80M | 0.75% |
| Apr 10, 2024 | 669.80M | -8.46% |
| Apr 9, 2024 | 731.70M | 4.17% |
| Apr 8, 2024 | 702.40M | -1.40% |
| Apr 5, 2024 | 712.40M | -1.85% |
| Apr 4, 2024 | 725.80M | -0.34% |
| Apr 3, 2024 | 728.30M | 4.69% |
| Apr 2, 2024 | 695.70M | -34.95% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alector | 512.77M |
| KalVista Pharmaceuticals | 512.17M |
| GeneDx Holdings | 510.47M |
| LifeMD | 508.65M |
| Orthofix Medical | 505.13M |
| UroGen Pharma | 500.40M |
| Nkarta | 500.32M |
| Travere Therapeutics | 498.45M |